FORWARD FEATURES CALENDAR

Allocations

OceanSound Partners closes Fund III at $3.4bn

Growth-focused private equity firm OceanSound Partners has completed the final close of its third fund, OceanSound Partners Fund III, LP, with $3.0bn in capital commitments plus an additional $0.4bn for related co-investment vehicles.

BC Partners hits €2.2bn at first close for Fund XII

BC Partners has raised approximately €2.2bn ($2.5bn) in initial commitments for its latest flagship vehicle, Fund XII, putting the firm nearly halfway to its target of €5bn, according to a report by Bloomberg citing unnamed sources familiar with the matter.

Blue Owl raises $2.9bn for Asset Special Opportunities Fund IX

Blue Owl Capital, an investor across credit, real assets, and GP strategic capital has completed the final close of its Asset Special Opportunities Fund IX, raising approximately $2.9bn in total capital commitments, surpassing its initial $2.5bn target.

Ares Management Corp

Latest Ares opportunistic credit fund attracts nearly $10bn

Ares Management has raised over $9.8bn for its opportunistic credit platform, completing the third fund in the series along with associated investment vehicles, even as private credit faces growing scrutiny, according to a report by the Wall Street Journal.

17Capital closes $7.5bn Credit Fund 2, setting NAV loan record

17Capital has completed the final close of Credit Fund 2 at approximately $7.5bn, including affiliated mandates, marking the largest fundraise for a NAV loan vehicle to date and bringing the firm’s total capital raised across eight funds since 2008 to more than $24bn.

Ares, Antares launch $1.7bn private credit continuation fund

Ares Management and Antares Capital have teamed up to create a $1.7bn continuation vehicle to recapitalise a portfolio of private-credit assets, marking their second such vehicle together in the past year, according to a report by teh Wall Street Journal.

Blackstone closes $6.3bn life sciences fund

Blackstone Inc has raised $6.3bn for its latest life-sciences fund, Blackstone Life Sciences VI, marking the firm’s largest capital raise for backing late-stage clinical trials of drugs and medical technologies, according to a report by Bloomberg.

Inflexion closes €4.5bn buyout fund in just six months

TOP STORY: European private equity firm Inflexion has raised €4.5bn for its latest buyout vehicle – Inflexion Buyout Fund VII (Fund VII) in just six months, exceeding its original €3.75bn target and surpassing its previous fund, which closed at £2.5bn in 2022.

Events

12 November, 2026 – 5:00 pm

Directory Listings